The CLEVER Study

People with peripheral arterial disease (PAD) are urgently needed to help with an important clinical trial. This trial will help determine what treatments work best. The trial seeks to identify people who have "intermittent claudication," which is usually experienced as thigh or calf muscle pain that occurs with walking and that always goes away with rest.

The CLEVER Study (Claudication: Exercise Versus Endoluminal Revascularization) is a clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Potential participants must have PAD and experience claudication symptoms. This study is comparing the effectiveness of exercise therapy versus endovascular treatment (stent placement) of aortoiliac disease.

If you live in one of the states or province listed below and want more information, visit www.cleverstudy.org or call toll-free 1-877-534-0533.

The Vascular Disease Foundation and any sponsors disclaim, either explicitly or implicitly, that any of the medications, treatments or devices listed here is safe or effective for the purposes under investigation, or that the test article is known to be equivalent or superior to any other drug, biologic or device. Additionally, no claims are made regarding the scientific utility and conduct of clinical trials or research studies listed.

VDF provides information about clinical trials as a public service and does not specifically endorse any of the trials listed. Consumers should thoroughly read consent forms and consult with their physicians before enrolling in any trial.

More information about clinical trials may be found at www.clinicaltrials.gov. New enrollment information for the ATTRACT trial for DVT and the BRIDGE trial will be listed soon on the clinical trial section of the VDF Web site www.vdf.org/clinical.

Visit it often to see other trials that are listed. You can help scientists determine better treatments for people with PAD by calling these programs to see if you can help.